HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for heparin as follows:
Heparin Sodium
Heparin sodium 25,000IU/5mL
ARTG 49236
This supply interruption is expected to be resolved by the end of December 2024.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. The alternative product is also preservative-free, and all packaging is in English.
Heparin is a high-risk medication. Additional care is recommended when selecting products, particularly when the packaging may be unfamiliar. The following table compares the Australian-registered product with the S19A alternative.
Heparin sodium 25000IU/5mL (Pfizer) | Heparin sodium (Wockhardt) preservative-free | |
Product type | Australian registered | S19A |
Excipients | Water for injection |
|
Pack size | 50 Steriluer ampoules | 10 neutral glass ampoules |
Storage | < 25°C | Do not store > 25°C Store in original package |
Additional information | Single-use only | Single-use only |
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer on 1800 675 229 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates